📗 Cite This Artifact
EIF2α Protein
EIF2α Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">EIF2α Protein</th>
</tr>
<tr>
<td class="label">Kinase</td>
<td>Stress Signal</td>
</tr>
<tr>
<td class="label">PERK (EIF2AK3)</td>
<td>ER stress/unfolded proteins</td>
</tr>
<tr>
<td class="label">GCN2 (EIF2AK4)</td>
<td>Amino acid starvation</td>
</tr>
<tr>
<td class="label">PKR (EIF2AK2)</td>
<td>Viral dsRNA</td>
</tr>
<tr>
<td class="label">HRI (EIF2AK1)</td>
<td>Heme deficiency/oxidative stress</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Relationship</td>
</tr>
<tr>
<td class="label">[PERK](/proteins/ire1)</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">GCN2</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">PKR</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">HRI</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">eIF2B</td>
<td>Target of p-EIF2α</td>
</tr>
<tr>
<td class="label">GADD34/PP1</td>
<td>Dephosphorylates Ser51</td>
</tr>
<tr>
<td class="label">ATF4</td>
<td>Translation enhanced</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a></td>
</tr>
EIF2α Protein
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">EIF2α Protein</th>
</tr>
<tr>
<td class="label">Kinase</td>
<td>Stress Signal</td>
</tr>
<tr>
<td class="label">PERK (EIF2AK3)</td>
<td>ER stress/unfolded proteins</td>
</tr>
<tr>
<td class="label">GCN2 (EIF2AK4)</td>
<td>Amino acid starvation</td>
</tr>
<tr>
<td class="label">PKR (EIF2AK2)</td>
<td>Viral dsRNA</td>
</tr>
<tr>
<td class="label">HRI (EIF2AK1)</td>
<td>Heme deficiency/oxidative stress</td>
</tr>
<tr>
<td class="label">Interactor</td>
<td>Relationship</td>
</tr>
<tr>
<td class="label">[PERK](/proteins/ire1)</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">GCN2</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">PKR</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">HRI</td>
<td>Phosphorylates Ser51</td>
</tr>
<tr>
<td class="label">eIF2B</td>
<td>Target of p-EIF2α</td>
</tr>
<tr>
<td class="label">GADD34/PP1</td>
<td>Dephosphorylates Ser51</td>
</tr>
<tr>
<td class="label">ATF4</td>
<td>Translation enhanced</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/fibrosis" style="color:#ef9a9a">Fibrosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">343 edges</a></td>
</tr>
</table>
<div style="float: right; margin: 0 0 1em 1em; padding: 1em; background: #f8f9fa; border: 1px solid #a2a9b1; border-radius: 5px; font-size: 0.9em; width: 280px;">
<strong>EIF2α</strong><br>
<i>Eukaryotic Translation Initiation Factor 2 Subunit Alpha</i>
<hr>
<strong>Symbol:</strong> EIF2S1 / EIF2A<br>
<strong>UniProt:</strong> [P05198](https://www.uniprot.org/uniprot/P05198)<br>
<strong>Gene:</strong> [EIF2S1](/entities/eif2s1)<br>
<strong>Molecular Weight:</strong> 36.1 kDa<br>
<strong>Location:</strong> Cytoplasm<br>
<strong>PDB:</strong> [3DW2](https://www.rcsb.org/structure/3DW2), [1KL9](https://www.rcsb.org/structure/1KL9)
</div>
Overview
Eukaryotic translation initiation factor 2 subunit alpha (EIF2α) is the regulatory subunit of the eIF2 heterotrimeric GTPase complex, which controls the rate-limiting step of protein synthesis initiation. Phosphorylation of EIF2α at Ser51 serves as the central hub for the integrated stress response (ISR), coordinating translational attenuation in response to diverse cellular stresses including ER stress, amino acid deprivation, viral infection, and oxidative damage[@wek2018].
In neurodegenerative diseases, aberrant EIF2α phosphorylation contributes to synaptic dysfunction, memory impairment, and neuronal death. The EIF2α pathway represents a major therapeutic target for Alzheimer's disease, Parkinson's disease, Huntington's disease, ALS, and prion disorders[@ma2020].
Structure and Domains
EIF2α contains:
- N-terminal domain (1-185): Contains the critical Ser51 phosphorylation site within a flexible loop; interacts with GTP-binding subunit
- Central β-barrel domain (186-280): Provides structural scaffold
- C-terminal OB-fold domain (281-315): Mediates interactions with eIF2β and eIF2γ subunits
The eIF2 complex delivers initiator methionyl-tRNA (Met-tRNAi) to the 40S ribosomal subunit in a GTP-dependent manner. GTP hydrolysis and GDP release are required for each translation initiation cycle[@hinnebusch2014].
Normal Function
Translation Initiation
eIF2•GTP•Met-tRNAi ternary complex formation is essential for every round of translation initiation. The complex:
Integrated Stress Response (ISR)
Four kinases phosphorylate EIF2α at Ser51 in response to distinct stressors[@donnelly2013]:
Phosphorylated EIF2α (p-EIF2α) inhibits eIF2B, the GTP exchange factor, reducing ternary complex availability and global protein synthesis by 50-90%[@pakoszebrucka2016].
Selective Translation
Paradoxically, p-EIF2α enhances translation of specific mRNAs with upstream open reading frames (uORFs), including:
- ATF4: Transcription factor activating stress response genes
- CHOP (DDIT3): Pro-apoptotic transcription factor
- GADD34: PPP1R15A, feedback phosphatase regulatory subunit
Role in Neurodegeneration
Alzheimer's Disease
In AD brains, elevated p-EIF2α and ATF4 levels correlate with disease progression[@hoozemans2007]:
- PERK activation: Accumulation of misfolded [Aβ](/proteins/amyloid-beta) and [tau](/proteins/tau) activates the [UPR](/entities/unfolded-protein-response)
- Synaptic plasticity: p-EIF2α impairs [long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and memory consolidation
- [BACE1](/entities/bace1) translation: Paradoxically, p-EIF2α increases BACE1 via uORF bypass, enhancing Aβ production
- Neuronal death: Sustained CHOP expression promotes [apoptosis](/entities/apoptosis)
eIF2α phosphorylation is elevated in hippocampal [neurons](/entities/neurons) of AD patients and [APP](/entities/app-protein)/PS1 transgenic mice[@oconnor2008].
Parkinson's Disease
- [α-synuclein](/proteins/alpha-synuclein) aggregates activate PERK in dopaminergic neurons
- PINK1/Parkin dysfunction impairs mitochondrial protein quality control, triggering ER stress
- Dopaminergic vulnerability: Substantia nigra neurons show elevated p-PERK and p-EIF2α
Post-mortem PD brains show increased p-PERK and p-EIF2α in surviving dopaminergic neurons[@hoozemans2005].
Huntington's Disease
- PolyQ-expanded [huntingtin](/proteins/huntingtin) disrupts ER homeostasis
- Chronic UPR activation contributes to striatal neuron degeneration
- BDNF translation: p-EIF2α impairs dendritic BDNF synthesis, affecting synaptic plasticity
ALS and FTD
- [TDP-43](/mechanisms/tdp-43-proteinopathy) cytoplasmic aggregates activate the ISR
- [C9orf72](/entities/c9orf72) dipeptide repeats induce ER stress
- SOD1 mutations trigger PERK activation in motor neurons
- FUS pathology associated with PERK-p-EIF2α signaling
Prion Diseases
- PrP^Sc accumulation activates PERK and PKR
- Sustained p-EIF2α critical for prion neurotoxicity
- ISRIB rescues prion-induced synaptic deficits in models
Therapeutic Targeting
ISRIB (Integrated Stress Response Inhibitor)
ISRIB stabilizes eIF2B, restoring translation despite p-EIF2α[@sidrauski2013]:
- Mechanism: Binds eIF2B, counteracts p-EIF2α-mediated inhibition
- Preclinical: Improves memory, protects neurons in AD/PD/HD models
- Clinical: Not yet in human trials for neurodegeneration
PERK Inhibitors
- GSK2606414: Potent PERK inhibitor, neuroprotective in prion and tau models
- GSK2656157: Improved brain penetration
- Limitations: Pancreatic toxicity due to essential PERK function in secretory cells
GCN2 Inhibitors
- A-92: Selective GCN2 inhibitor
- Potential: May reduce ISR in specific contexts
Salubrinal
- Mechanism: Inhibits GADD34/PP1 phosphatase, sustaining p-EIF2α
- Paradox: Protective in some models, harmful in others
- Interpretation: Context-dependent; acute vs chronic activation
Key Interactions
See Also
- [Unfolded Protein Response](/mechanisms/er-stress-upr)
External Links
- [UniProt: P05198](https://www.uniprot.org/uniprot/P05198)
- [PDB structures](https://www.rcsb.org/search?q=uniprot:P05198)
References
Pathway Diagram
Pathway Diagram
The following diagram shows the key molecular relationships involving EIF2α Protein discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-eif2a |
| kg_node_id | EIF2A |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-9eac8330389e |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-eif2a'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-eif2a?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[EIF2α Protein](http://scidex.ai/artifact/wiki-proteins-eif2a)
http://scidex.ai/artifact/wiki-proteins-eif2a